Rotavirus vaccine
Overview
The rotavirus vaccine virus is excreted in the stool and may be transmitted to close contacts; the vaccine should be used with caution in those with immunosuppressed close contacts. Carers of a recently vaccinated baby should be advised of the need to wash their hands after changing the baby’s nappies. Rotavirus vaccine (live, oral) is licensed for immunisation of infants over 6 weeks of age for protection against gastro-enteritis caused by rotavirus infection.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Rotavirus vaccine's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| No data regarding the Adult dosage details of Rotavirus vaccine is available. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Rotavirus vaccine is available. |
Neonatal Dosage (3kg)
|
| 1 | 1 (1) | As recommended. | PO | Two doses are given, the first at 6 weeks of age onwards and the subsequent dose at least 4 weeks later; the course should preferably be given before 16 weeks of age, but must be completed by the age of 24 weeks. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Rotavirus vaccine
Back to top
Manufacturers of
Rotavirus vaccine
in Pakistan
Back to top
Previous Drug Generic - Next Drug Generic